Jeffrey M. Weinfeld, MD, MBI
Kathryn M. Hart, MD
Jose D. Vargas, MD, PhD

American Family Physician. 2021;104(3):237-243.

Author disclosure: No relevant financial affiliations.

Patient information: See related handout on checking blood pressure at home, written by the authors of this article.

Home blood pressure monitoring provides important diagnostic information beyond in-office blood pressure readings and offers similar results to ambulatory blood pressure monitoring. Home blood pressure monitoring involves patients independently measuring their blood pressure with an electronic device, whereas ambulatory blood pressure monitoring involves patients wearing a portable monitor for 24 to 48 hours. Although ambulatory blood pressure monitoring is the diagnostic standard for measurement, home blood pressure monitoring is more practical and accessible to patients, and its use is recommended by the U.S. Preventive Services Task Force and the American College of Cardiology/American Heart Association. Home blood pressure monitoring generally results in lower blood pressure readings than in-office measurements, can confirm the diagnosis of hypertension after an elevated office blood pressure reading, and can identify patients with white coat hypertension or masked hypertension. Best practices for home blood pressure monitoring include using an appropriately fitting upper-arm cuff on a bare arm, emptying the bladder, avoiding caffeinated beverages for 30 minutes before taking the measurement, resting for five minutes before taking the measurement, keeping the feet on the floor uncrossed and the arm supported with the cuff at heart level, and not talking during the reading. An average of multiple readings, ideally two readings in the morning and again in the evening separated by at least one minute each, is recommended for one week. Home blood pressure readings can be used in hypertension quality measures.

The home measurement of blood pressure allows patients with hypertension to become more involved in their care and allows clinicians to diagnose hypertension and monitor therapy more accurately. Evidence shows that home blood pressure measurements are generally lower than blood pressure measured in a clinician's office.1,2 The current expansion of telemedicine has increased the need to monitor blood pressure at home and decreased the number of in-office blood pressure measurements.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating Comments
To diagnose hypertension based on readings from a home blood pressure monitor, patients should obtain two measurements separated by at least one minute twice per day. Patients should be instructed to record their readings over the course of three (minimum) to seven (ideal) days. These readings should then be averaged.6,912 C Primary literature based on randomized controlled trials, a cross-sectional study, and disease-oriented evidence
Home blood pressure monitoring or ambulatory blood pressure monitoring can identify several hypertension patterns, including confirmed, white coat, and masked, with the goal of reducing cardiovascular events.9,14,15 A U.S. Preventive Services Task Force and American College of Cardiology/American Heart Association guidelines, and primary literature based on good-quality patient-oriented evidence and limited-quality patient-oriented evidence
Patients should be encouraged to use a validated and fully automated blood pressure measurement device with an appropriately sized upper arm cuff that stores measurements.9 C Expert opinion based on American Heart Association guidelines and validation protocols
Patients should be educated on proper technique to obtain the most accurate reading from a home blood pressure monitor. During the measurement, patients should be seated with their back supported, legs uncrossed, feet flat on the floor, and arm resting on a flat surface and should avoid talking and texting.9,15 C Expert opinion based on American Heart Association guidelines and validation protocols

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

Historically, blood pressure has been measured in a clinician's office using auscultation and a mercury or aneroid cuff. Many practices now use automated office blood pressure devices that were initially used in clinical studies. In the Systolic Blood Pressure Intervention Trial, patients were placed in a room where an automated device was used to take an average of several blood pressure measurements after a five-minute rest.3 However, out-of-office measurement of blood pressure (notably ambulatory blood pressure monitoring and home blood pressure monitoring) provide additional diagnostic information about blood pressure.

Ambulatory Blood Pressure Monitoring

Ambulatory blood pressure monitoring involves patients wearing a portable device for 24 to 48 hours. Blood pressure is measured at regular intervals while the patient is at home doing normal activities. It is considered the most accurate method for measuring blood pressure and diagnosing hypertension.

Information on how to implement ambulatory blood pressure monitoring has been published in the FPM journal.4 Ambulatory blood pressure monitoring requires that a patient obtain a monitoring device from the clinician's office and use it continuously for a full monitoring period. The device is then returned to the clinician so that the data can be downloaded and interpreted.

Higher systolic blood pressure readings on ambulatory blood pressure monitoring positively correlate with total mortality and cardiovascular outcomes.5 Ambulatory blood pressure monitoring can also detect blood pressure variables associated with an increased risk of cardiovascular events, such as blood pressure measurements that are higher in the morning than in the evening.6

Although ambulatory blood pressure monitoring provides a thorough blood pressure report with validated variables, it is not widely available outside of academic medical centers. Home blood pressure monitoring is an alternative method and the focus of this article.

Home Blood Pressure Monitoring

Home blood pressure monitoring involves patients independently measuring their blood pressure with an electronic device. Combining home blood pressure monitoring with remote or telephone physician monitoring of results (i.e., self-measured blood pressure with clinician support) is a strategy recommended by the Centers for Disease Control and Prevention Community Preventive Services Task Force.7

Home blood pressure monitoring is more sensitive (90% vs. 81%) and more specific (84% vs. 76%) than in-office blood pressure measurements for the diagnosis of hypertension when ambulatory blood pressure monitoring is used as the reference standard.8 The American Heart Association recommends two measurements separated by at least one minute twice per day to diagnose hypertension using home blood pressure monitoring. Patients should be instructed to record their readings for three (minimum) to seven (ideal) days leading up to their clinic appointment.912 Some guidelines recommend omitting the first day of readings because they tend to be more elevated than other readings.10,13 The recorded readings should be averaged.

Home blood pressure monitoring received increased attention in 2015 when the U.S. Preventive Services Task Force recommended using out-of-office measurements to confirm hypertension before initiating treatment; this recommendation was reaffirmed in 2021.14 The 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline for high blood pressure in adults also recommends out-of-office blood pressure monitoring for confirmation of hypertension and titration of pharmaceutical treatment. However, the guideline states that in-office measurement is acceptable for diagnosis of hypertension if proper techniques are used.15 The ACC/AHA guideline provides a table that correlates blood pressure measured in the office with the generally lower readings using home blood pressure monitoring and ambulatory blood pressure monitoring (Table 1).15

TABLE 1. Comparison of Office, Home, and 24-hour Ambulatory Blood Pressure Measurements

Office (mm Hg)Home (mm Hg)24-hour ambulatory (mm Hg)
120/80120/80115/75
130/80130/80125/75
140/90135/85130/80
160/100145/90145/90

Note: In-office blood pressure measurements are progressively higher than home or ambulatory blood pressure measurements as blood pressure increases.

Adapted with permission from Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [published correction appears in J Am Coll Cardiol. 2018;71(19):2273–2275]. J Am Coll Cardiol. 2018;71(19):2211.

Types of Hypertension Detectable Using Blood Pressure Monitoring

Home blood pressure monitoring or ambulatory blood pressure monitoring (if available) can identify several hypertension patterns, including confirmed, white coat, and masked hypertension.9,14,15 Although ambulatory blood pressure monitoring may be more accurate, home blood pressure monitoring is often more practical in routine practice.

The ACC/AHA guidelines define hypertension as blood pressure above 130/80 mm Hg.15 The 2014 Eighth Joint National Committee guideline, which is endorsed by the American Academy of Family Physicians, uses a cutoff of 140/90 mm Hg for adults younger than 60 years,16,17 and the American College of Physicians/American Academy of Family Physicians definition uses a cutoff of 150/90 mm Hg for patients 60 years and older.18

CONFIRMED HYPERTENSION

Confirmed hypertension occurs when ambulatory blood pressure monitoring or home blood pressure monitoring and in-office measurements are both in the hypertension range.15

WHITE COAT HYPERTENSION

White coat hypertension is identified when a patient's blood pressure is elevated in the office but is normal at home. Although there is controversy about the prognostic significance of white coat hypertension, home measurements allow it to be distinguished from confirmed hypertension.19,20

Figure 1 describes the use of home blood pressure monitoring in differentiating white coat hypertension from confirmed hypertension.15 Clinicians should consider white coat hypertension and arrange for home blood pressure monitoring (or ambulatory blood pressure monitoring) when office blood pressure is consistently in the hypertension range after a three-month trial of lifestyle modification and without evidence of end-organ damage.

FIGURE 1.

Algorithm for the diagnosis of suspected white coat hypertension.

Information from reference 15.

MASKED HYPERTENSION

Masked hypertension occurs when blood pressure is normal in the office but elevated at home. Patients with masked hypertension have a similar risk of cardiovascular events as patients with sustained hypertension and about two times the risk of those who have normal blood pressure.21

Figure 2 outlines the use of home blood pressure monitoring to diagnose masked hypertension, which should be suspected when in-office blood pressure is consistently mildly elevated and there is evidence of end-organ damage or the patient has significant cardiovascular risk factors.15 Masked hypertension is confirmed when home blood pressure monitoring demonstrates readings in the hypertension range.

FIGURE 2.

Algorithm for the diagnosis of suspected masked hypertension.

Information from reference 15.

Home Blood Pressure Monitoring in Hypertension Therapy

For patients who are taking medications for hypertension, home blood pressure monitoring is useful for ongoing monitoring of therapy. Because pretreatment home blood pressure is generally lower than in-office blood pressure, therapy may appear to decrease home blood pressure less than in-office blood pressure (by 12.2/8.0 mm Hg vs. by 15.2/10.3 mm Hg)—showing that home blood pressure falls about 20% less than in-office blood pressure with treatment.22

For patients whose in-office blood pressure is above goal when taking medication, the ACC/AHA guideline suggests checking home blood pressure to eliminate the possibility of white coat hypertension.15 No further medication adjustment is recommended if blood pressure is at goal on home blood pressure monitoring, even if measurements are elevated in the office.15

When in-office blood pressure is at goal during therapy in patients with increased cardiovascular risk or known target organ damage, the guideline recommends screening for uncontrolled masked hypertension. In this situation, in-office blood pressure appears controlled, but home or ambulatory blood pressure is above goal, necessitating an increase in therapy.

Best Practices for Home Blood Pressure Monitoring

Patients should be encouraged to use a validated and fully automated blood pressure measurement device with an appropriately sized upper arm cuff that stores measurements.9 Blood pressure monitors that have been validated according to accepted protocols are provided by the U.S. Blood Pressure Validated Device Listing (https://www.validatebp.org) and The Dabl Educational Trust (http://www.dableducational.org/sphygmomanometers/devices_2_sbpm.html#ArmTable); these lists are endorsed by the American Medical Association and American Heart Association, respectively.9,2326

To determine cuff size, patients should measure their arm circumference at the midpoint of the upper arm. The bladder length should be 75% to 100% of the arm circumference, and bladder width should be 37% to 50% of the arm circumference.9

Using a validated home blood pressure cuff for home blood pressure monitoring counts toward some hypertension quality measures depending on the measure year and interpretation.27,28 The electronic clinical quality measure for 2022 from the Centers for Medicare and Medicaid Services allows readings taken by a remote device and conveyed by the patient.29 Patients should be encouraged to bring their home blood pressure monitoring device with readings to their visit. The lowest systolic and diastolic measurements from a single date may be recorded in the electronic health record. [corrected]

Patients should be educated on proper technique to obtain the most accurate reading from a home blood pressure monitor. In preparation for a measurement, patients should avoid physical activity, caffeine, or other stimulants for 30 minutes, have an empty bladder, and rest quietly and avoid talking or texting for five minutes.9,15 The cuff should be placed tautly on a bare arm just proximal to the antecubital fossa, with the center of the cuff (typically inscribed by the manufacturer) over the brachial artery. During the measurement, the patient should continue to avoid talking and texting, and sit with their back supported, legs uncrossed, feet flat on the floor, and arm resting on a flat surface with the cuff at heart level (Figure 3).9,15

FIGURE 3.

Proper positioning for accurate home blood pressure monitoring. The patient should be seated with their back supported, legs uncrossed, feet flat on the floor, and arm resting on a flat surface. The cuff should be placed on a bare upper arm at heart level.

Information from references 9 and 15.

Wrist and Kiosk Blood Pressure

Wrist cuffs are not recommended because they have significant limitations that can decrease their accuracy.9 The wrist must be positioned at heart level with the sensor directly over the radial artery—positioning that may be difficult for patients to maintain throughout a blood pressure measurement.30,31 If a patient continues to use a wrist cuff, they should be educated about the need to closely follow the manufacturer's instructions.

Blood pressure kiosks located in pharmacies and grocery stores are not a substitute for home blood pressure monitoring. Many kiosks have not been validated by standard protocols, and there are limited data on the reproducibility of their readings.32,33 Kiosks typically have inadequate back support and a single cuff size that is too small for many adults.34

Cost and Insurance Coverage

For patients without medical insurance, the cost of a home blood pressure monitor ranges from $37 to $100.35 Cost can be a barrier to the routine use of home blood pressure monitoring for patients with low-income.

Medicare part B covers ambulatory blood pressure monitoring for suspected masked and white coat hypertension but does not cover home blood pressure monitoring devices.36,37 Many Medicaid, private, and self-insured employer plans cover home monitors, varying by state, but only if hypertension has been diagnosed.9 Flexible spending accounts often can be used for home monitors.

In 2020, the Centers for Medicare and Medicaid Services added new Current Procedural Terminology (CPT) codes to support hypertension management using home blood pressure monitoring. Code 99473 is for self-measured blood pressure using a device validated for clinical accuracy, as well as patient education/training and device calibration. Code 99474 involves collecting separate self-measurements of two readings one minute apart, twice per day over 30-days (minimum of 12 readings) by a patient or caregiver, report of averages systolic and diastolic readings, and subsequent communication of a treatment plan. Reimbursement is $11 for 99473 and $15 for 99474.38

This article updates a previous article on this topic by Taylor and Campbell.39

Data Sources: A search was completed in PubMed, the Cochrane database, and Essential Evidence Plus using the key terms ambulatory blood pressure, home blood pressure monitoring, hypertension, and hypertension screening. Search dates: June 2020, March 2021, and July 2021.

Figure 3 provided by Brian Hart.

JEFFREY M. WEINFELD, MD, MBI, FAAFP, is director of medical student education and a professor in the Department of Family Medicine at Georgetown University School of Medicine, Washington, D.C.

KATHRYN M. HART, MD, FAAFP, is director of the Primary Care Leadership Track and an associate professor in the Department of Family Medicine at Georgetown University School of Medicine.

JOSE D. VARGAS, MD, PhD, is an attending physician and assistant professor in the Department of Cardiology at MedStar Georgetown University Hospital.

Address correspondence to Jeffrey M. Weinfeld, MD, MBI, FAAFP, Georgetown University School of Medicine, 3900 Reservoir Rd. NW, GM4C Pre-Clinical Sciences, Washington, DC 20007. Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

  1. 1.Piper MA, Evans CV, Burda BU, et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(3):192-204.
  2. 2.Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010(3):CD005182.
  3. 3.Wright JT, Williamson JD, Whelton PK, et al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control [published correction appears in N Engl J Med. 2017;377(25):2506]. N Engl J Med. 2015;373(22):2103-2116.
  4. 4.Kronish IM, Hughes C, Quispe K, et al. Implementing ambulatory blood pressure monitoring in primary care practice. Fam Pract Manag. 2020;27(3):19-25. Accessed May 24, 2021. https://www.aafp.org/fpm/2020/0500/p19.html
  5. 5.Yang WY, Melgarejo JD, Thijs L, et al.; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322(5):409-420.
  6. 6.Pickering TG, Miller NH, Ogedegbe G, et al.; American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses Association. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1-9.
  7. 7.The Community Preventive Services Task Force. Cardiovascular disease: self-measured blood pressure monitoring interventions for improved blood pressure control – when combined with additional support. June 2015. Accessed October 10, 2020. https://www.thecommunityguide.org/findings/cardiovascular-disease-self-measured-blood-pressure-with-additional-support
  8. 8.Constanti M, Boffa R, Floyd CN, et al. Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model. J Hum Hypertens. 2021;35(5):455-461.
  9. 9.Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73(5):e35-e66.
  10. 10.Stergiou GS, Skeva II, Zourbaki AS, et al. Self-monitoring of blood pressure at home: how many measurements are needed?. J Hypertens. 1998;16(6):725-731.
  11. 11.Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, et al. The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens. 2010;24(3):158-164.
  12. 12.Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368-2374.
  13. 13.Parati G, Stergiou GS, Asmar R, et al.; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779-785.
  14. 14.Krist AH, Davidson KW, Mangione CM, et al. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325(16):1650-1656.
  15. 15.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2018;71(19):2273–2275]. J Am Coll Cardiol. 2018;71(19):2199-2269.
  16. 16.James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published correction appears in JAMA. 2014;311(17):1809]. JAMA. 2014;311(5):507-520.
  17. 17.American Academy of Family Physicians. Clinical practice guideline. Hypertension. Accessed May 24, 2021. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/highbloodpressure.html
  18. 18.Qaseem A, Wilt TJ, Rich R, et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians [published correction appears in Ann Intern Med. 2018;168(7):530–532]. Ann Intern Med. 2017;166(6):430-437.
  19. 19.Mancia G, Bombelli M, Brambilla G, et al. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension. 2013;62(1):168-174.
  20. 20.Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193-2198.
  21. 21.Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-515.
  22. 22.Ishikawa J, Carroll DJ, Kuruvilla S, et al. Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension. 2008;52(5):856-864.
  23. 23.Tholl U, Anlauf M, Lichtblau U, et al. The Stamp of Quality (Prüfsiegel) of the German Hypertension League for the clinical validation of blood pressure measuring devices. Results from the testing of 51 devices [in German]. Dtsch Med Wochenschr. 2006;131(46 Spec No):H31-H36.
  24. 24.O'Brien E, Petrie J, Littler W, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11(6):677-679.
  25. 25.O'Brien E, Atkins N, Stergiou G, et al.; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults [published correction appears in Blood Press Monit. 2010;10(3):171–172]. Blood Press Monit. 2010;15(1):23-38.
  26. 26.The Dabl Educational Trust. Sphygmomanometers for self-measurement of blood pressure. Accessed October 13, 2020. http://www.dableducational.org/sphygmomanometers/devices_2_sbpm.html#ArmTable
  27. 27.National Quality Forum. Controlling high blood pressure. November 20, 2020. Accessed October 13, 2020. https://bit.ly/3BrA2MF
  28. 28.eCQI Resource Center. Controlling high blood pressure. eCQMs for 2021 performance period. Accessed October 12. 2021. https://ecqi.healthit.gov/ecqm/ep/2021/cms165v9?qt-tabs_measure=0
  29. 29.eCQI Resource Center. Controlling high blood pressure. eCQMs for 2022 performance period. Accessed October 12. 2021. https://ecqi.healthit.gov/ecqm/ep/2022/cms165v10
  30. 30.Thomas SS, Nathan V, Zong C, et al. BioWatch: a noninvasive wrist-based blood pressure monitor that incorporates training techniques for posture and subject variability. IEEE J Biomed Health Inform. 2016;20(5):1291-1300.
  31. 31.Casiglia E, Tikhonoff V, Albertini F, et al. Poor reliability of wrist blood pressure self-measurement at home: a population-based study. Hypertension. 2016;68(4):896-903.
  32. 32.Alpert BS, Dart RA, Sica DA. Public-use blood pressure measurement: the kiosk quandary. J Am Soc Hypertens. 2014;8(10):739-742.
  33. 33.Al Hamarneh YN, Houle SKD, Chatterley P, et al. The validity of blood pressure kiosk validation studies: a systematic review. Blood Press Monit. 2013;18(3):167-172.
  34. 34.Ostchega Y, Hughes JP, Zhang G, et al. Mean mid-arm circumference and blood pressure cuff sizes for U.S. adults: National Health and Nutrition Examination Survey, 1999–2010. Blood Press Monit. 2013;18(3):138-143.
  35. 35.Recommended blood pressure monitors. Consumer Reports. Accessed March 3, 2021. https://www.consumerreports.org/products/blood-pressure-monitors-33078/blood-pressure-monitor-33754/recommended
  36. 36.Centers for Medicare and Medicaid Services. Decision memo for ambulatory blood pressure monitoring. Accessed October 22, 2020. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=294
  37. 37.Centers for Medicare and Medicaid Services. Durable medical equipment (DME) coverage. Accessed October 22, 2020. https://www.medicare.gov/coverage/durable-medical-equipment-dme-coverage
  38. 38.Moore KJ, Mullins A, Solis E, et al. The 2020 Medicare documentation, coding, and payment update. Fam Pract Manag. 2020:27(1):8–13. Accessed May 24, 2021. https://www.aafp.org/fpm/2020/0100/p8.html
  39. 39.Taylor JR, Campbell KM. Home monitoring of glucose and blood pressure. Am Fam Physician. 2007;76(2):255-260. Accessed May 12, 2021. https://www.aafp.org/afp/2007/0715/p255.html

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.